Mesalamine premix-based delayed release formulation and its efficacy assessment using a 3D in-vitro gut model for inflammatory bowel disease
Fields of Study & Subjects
Drug Solubulity and Delivery Systems
Advanced Drug Delivery Systems
Inflammatory Bowel Disease
Publication details
- Journal / source
- Journal of Controlled Release
- Volume
- 392
- Pages
- 114672–114672
- Publication date
- 28 January 2026
- Language
- EN